Prognostic factors for diffuse large B-cell lymphoma: clinical and biological factors in the rituximab era

被引：2
|
作者：
Liang, Xiping [1 ]
Hu, Renzhi [1 ]
Li, Qiying [1 ]
Wang, Chaoyu [1 ]
Liu, Yao [1 ]
机构：
[1] Chongqing Univ, Dept Hematol Oncol, Canc Hosp, Chongqing Key Lab Translat Res Canc Metastasis & I, Chongqing, Peoples R China
来源：
EXPERIMENTAL HEMATOLOGY | 2023年 / 122卷
关键词：
NCCN-IPI; EXPRESSION; CLASSIFICATION; BIOMARKER; SURVIVAL; ACCURATE; SUBTYPES; MARKER; DNA;
D O I：
10.1016/j.exphem.2023.03.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 9
页数：9
相关论文
共 50 条
  • [41] Is there any role for transplantation in the rituximab era for diffuse large B-cell lymphoma?
    Gisselbrecht, Christian
    HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2012, : 410 - 416
  • [42] Clinical characteristics and prognostic factors in diffuse large B-cell lymphoma with bone marrow involvement.
    Lee, K.
    Yi, J.
    Choi, I.
    Kim, J.
    Kim, D.
    Lee, J.
    Heo, D.
    Bang, Y.
    Cho, H.
    Kim, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 443S - 443S
  • [43] Prognostic factors in patients with diffuse large B cell lymphoma: Before and after the introduction of rituximab
    Ngo, Lynette
    Hee, Siew-Wan
    Lim, Lay-Cheng
    Tao, Miriam
    Quek, Richard
    Yap, Swee-Peng
    Loong, Er-Li
    Sng, Ivy
    Hwan-Cheong, Tan Leonard
    Ang, Mei-Kim
    Ngeow, Joanne
    Tham, Chee-Kian
    Tan, Min-Han
    Lim, Soon-Thye
    LEUKEMIA & LYMPHOMA, 2008, 49 (03) : 462 - 469
  • [44] Prognostic factors in diffuse large B-cell lymphoma at diagnosis (international prognostic index excluded)
    Calvani, Julien
    Meignin, Veronique
    Vercellino, Laetitia
    Thieblemont, Catherine
    HEMATOLOGIE, 2021, 27 : 5 - 17
  • [45] Stem cell transplantation for diffuse large B-cell lymphoma patients in the rituximab era
    Mounier, Nicolas
    Gisselbrecht, Christian
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (02) : 209 - 213
  • [46] Prognostic Factors in Elderly Patients with Diffuse Large B-Cell Lymphoma and Their Treatment Results
    Adiyaman, Suleyman Cem
    Alacacioglu, Inci
    Danyeli, Ayca Ersen
    Turkyilmaz, Dogus
    Sevindik, Omur Gokmen
    Demirkan, Fatih
    Piskin, Ozden
    Ozcan, Mehmet Ali
    Undar, Bulent
    Ozkal, Sermin
    Ozsan, Guner Hayri
    TURKISH JOURNAL OF HEMATOLOGY, 2019, 36 (02) : 81 - 87
  • [47] Osteopontin expression and its relationship with prognostic factors in diffuse large B-cell lymphoma
    Barranco, Gilberto
    Fernandez, Edith
    Rivas, Silvia
    Quezada, Roxana
    Nava, Dolores
    Aguilar, Jose
    Garcia, Abelardo
    Astudillo, Horacio
    Lome, Carmen
    Ruiz, Erika
    HEMATOLOGY REPORTS, 2019, 11 (03) : 55 - 58
  • [48] Prognostic factors and outcome in 306 patients with diffuse large B-cell lymphoma (DLBCL)
    Oyan, Basak
    Tekuzman, Gulten
    Barista, Ibrahim
    Ozisik, Yavuz
    kars, Ayse
    Turker, Alev
    Yalcin, Suayib
    Guler, Nilufer
    Koc, Yener
    Kansu, Emin
    ANNALS OF ONCOLOGY, 2004, 15 : 153 - 153
  • [49] Analysis of prognostic factors in diffuse large B-cell lymphoma associated with rheumatic diseases
    Gorodetskiy, Vadim
    Probatova, Natalya
    Obukhova, Tatiana
    Vasilyev, Vladimir
    LUPUS SCIENCE & MEDICINE, 2021, 8 (01):
  • [50] Paramount prognostic factors that guide therapeutic strategies in diffuse large B-cell lymphoma
    Sehn, Laurie H.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2012, : 402 - 409
12345